Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia

Published:2010-11-18 Issue:1 Volume:152 Page:61-71
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Elliott Sarah L.,Crawford Clark,Mulligan Evan,Summerfield Geoffrey,Newton Paula,Wallis Jonathan,Mainou-Fowler Tryfonia,Evans Paul,Bedwell Clare,Durkacz Barbara W.,Willmore Elaine

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08425.x/fullpdf

Reference29 articles.

1. Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage;Adachi;Biochemical and Biophysical Research Communications,2004

2. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase;Amrein;Journal of Pharmacology and Experimental Therapeutics,2007

3. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL;Austen;Blood,2005

4. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias;Beck;Cancer Letters,1994

5. Expression of MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias;Beck;Leukemia,1996

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Potential Therapeutic Roles of PRKDC Expression in Lung Cancer;Molecular Biotechnology;2024-07-24

2. The multifaceted functions of DNA‐PKcs: implications for the therapy of human diseases;MedComm;2024-06-19

3. Targeting the DNA damage response in hematological malignancies;Frontiers in Oncology;2024-01-29

4. Prognostic and potential therapeutic roles of PRKDC expression in lung cancer;2023-11-14

5. SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia;International Journal of Molecular Sciences;2023-07-12